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Trichomoniasis caused by the parasitic protozoan Tricho-
monas vaginalis is the most common sexually transmitted dis-
ease in the world. Dendritic cells are antigen presenting cells 
that initiate immune responses by directing the activation and 
differentiation of naïve T cells. In this study, we analyzed the 
effect of Trichomonas vaginalis-derived Secretory Products on 
the differentiation and function of dendritic cells. Differentia-
tion of bone marrow-derived dendritic cells in the presence of 
T. vaginalis-derived Secretory Products resulted in inhibition of 
lipopolysaccharide-induced maturation of dendritic cells, 
down-regulation of IL-12, and up-regulation of IL-10. The pro-
tein components of T. vaginalis-derived Secretory Products were 
shown to be responsible for altered function of bone mar-
row-derived dendritic cells. Chromatin immunoprecipitation 
assay demonstrated that IL-12 expression was regulated at the 
chromatin level in T. vaginalis-derived Secretory Products- 
treated dendritic cells. Our results demonstrated that T. vagi-
nalis-derived Secretory Products modulate the maturation and 
cytokine production of dendritic cells leading to immune 
tolerance. [BMB Reports 2015; 48(2): 103-108]
INTRODUCTION
Dendritic cells (DCs) are professional antigen-presenting cells 
that provide a pivotal link between the external environment 
and the adaptive immune response (1). Maturation and activa-
tion of DCs involve enhanced expression of several molecules 
that play key roles in antigen presentation and co-stimulation 
such as major histocompatibility complex II (MHC-II), CD80, 
CD86, and CD40, in concert with the release of cytokines that 
influence the type and intensity of the immune responses (2). 
While the immune responses induced by DCs are critical to 
control and eliminate the invading pathogens, DCs are equally 
responsible for the maintenance of immune tolerance to pre-
vent destructive autoimmune reactions against healthy tissues 
(3). In addition, reports have demonstrated that parasites can 
interfere with DC activity in order to promote a permissive en-
vironment for survival inside their host (4).
Trichomonas vaginalis is an extracellular flagellated proto-
zoan parasite that infects the squamous epithelium of the geni-
tal tract of both females and males (5). It is responsible for tri-
chomoniasis, one of the most common non-viral sexually 
transmitted diseases in the world (6). Typical symptoms in in-
fected women include a purulent and frothy vaginal discharge 
accompanied by pruritus (7). Vaginal infection is associated 
with adverse outcomes of pregnancy (8), increased incidence 
of cervical cancer (9), and increased transmission of human 
immunodeficiency virus (HIV) (10).
Infection with T. vaginalis leads to an aggressive local cel-
lular immune response with inflammation of the vaginal epi-
thelium in women and the urethra of men (11, 12). T. vagi-
nalis frequently causes punctate mucosal hemorrhages, which 
potentially compromise the mechanical barrier to infection 
(13). In addition, human neutrophils and macrophages stimu-
lated with live T. vaginalis produce the chemokine IL-8 and 
the acute pro-inflammatory cytokines IL-6, TNF-α and IL-1β 
that are responsible for initiating the immune response to in-
fection by recruiting immune cells (14, 15). However, the host 
immune response frequently fails to clear T. vaginalis, leading 
to chronic infection. There is evidence that T. vaginalis in-
fection can induce a state of non-responsiveness to subsequent 
stimulation with bacterial lipopolysaccharide (LPS) (16). Contact 
of macrophages with T. vaginalis led to inhibition of proin-
flammatory cytokine production (by suppressing NF-κB activa-
tion (16)) and induction of immunosuppressive cytokine IL-10 
production by human DCs (17). It also has been reported that 
T. vaginalis can induce macrophage apoptosis through phos-
phorylation of p38 mitogen-activated protein (MAP) kinase 
(18).
The pathogenicity of T. vaginalis is influenced by its contact 
with epithelial cells; however, various soluble factors secreted 
from T. vaginalis also have been shown to modulate host im-
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Fig. 1. The effect of TvSP on the expression of surface molecules 
on BMDC. DCs were differentiated with GM-CSF from BM pre-
cursors in the absence or presence of TvSP. On day 10, DCs were
treated with 100 ng/ml LPS for 24 h to induce maturation, and 
expression of MHC-II (A), CD40 (B), CD80 (C) and CD86 (D) was 
analyzed by flow cytometry. Isotype controls are shown as shaded
histograms, control BMDCs are shown as red lines, and TvSP-treated
BMDCs are shown as blue lines. Mean fluorescent intensity (MFI) 
values are indicated with corresponding colors. Results are repre-
sentative of more than three independent experiments.
mune responses. Recent studies showed that T. vaginalis can 
secrete leukotriene B4, which binds to Leukotriene B4 re-
ceptors BLT1 and BLT2 on neutrophils and mast cells leading 
to production of IL-8 (19, 20). However, there is little infor-
mation elucidating how T. vaginalis-derived Secretory Products 
(TvSP) affect the differentiation and maturation of DCs, which 
is critical given the crucial role of DCs in both the innate and 
adaptive immune responses.
In this study, we investigated the effect of TvSP on the sur-
face molecule expression and cytokine secretion profile of 
DCs using an in vitro murine bone marrow-derived dendritic 
cell (BMDC) model.
RESULTS
TvSP down-regulate the expression of MHC-II and 
co-stimulatory molecules
To test whether TvSP affect differentiation and function of 
BMDC, bone marrow (BM) cells were cultured with gran-
ulocyte macrophage colony-stimulating factor (GM-CSF) in the 
presence or absence of TvSP for 10 days and then stimulated 
with LPS for 18 h to induce maturation of DCs. TvSP did not 
trigger apoptosis in BMDCs during GM-CSF-mediated differ-
entiation (Supplementary Fig. 1). In the absence of TvSP, BM 
cells differentiated into DCs that displayed the typical surface 
phenotypes of immature and mature DCs (Fig. 1). When BM 
cells were differentiated in the presence of TvSP, however, the 
expression of MHC-II and co-stimulatory molecules such as 
CD40, CD80, and CD86 was down-regulated or at least re-
main unaltered in immature BMDCs (Fig. 1). The down-regu-
lation of MHC-II and co-stimulatory molecules by TvSP was 
much more evident when DCs were stimulated with LPS (Fig. 1). 
These results suggest that TvSP impair the antigen-presenting 
capacity of DCs during DC differentiation by diminishing the 
expression of MHC-II and co-stimulatory molecules. 
Cytokine production by BMDC differentiated in the presence 
of TvSP
In order to examine whether TvSP may affect the cytokine pro-
duction capacity of BMDCs during DC differentiation, we per-
formed quantitative real-time Polymerase Chain Reaction 
(qRT-PCR) using BMDCs that were differentiated in the ab-
sence or presence of TvSP for 10 days and then stimulated 
with LPS. This analysis demonstrated that the mRNA levels of 
Il12a, Il12b, Il10, Tnf, and Il6 were markedly increased by LPS 
stimulation in control BMDCs, consistent with a previous re-
port (2). Interestingly, the induction of Il12a and Il12b mRNA 
expression in response to LPS was significantly lower in 
BMDCs differentiated in the presence of TvSP compared to the 
BMDCs differentiated in the absence of TvSP (Fig. 2A and 2B). 
In contrast, differentiation of BMDCs in the presence of TvSP 
resulted in higher expression of the immunosuppressive cyto-
kine Il10 compared to the control BMDCs (Fig. 2C). TvSP ex-
erted a minimal effect on the mRNA expression of other proin-
flammatory cytokines such as Tnf and Il6 (Fig. 2D and 2E). 
The effect of TvSP on the cytokine production profile of 
BMDCs also was analyzed at the protein level. The LPS-medi-
ated induction of IL-12 was significantly diminished in 
TvSP-treated BMDCs (Fig. 2F), while production of IL-10 was 
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Fig. 2. The effect of TvSP on the cytokine production of BMDC. DCs were differentiated with GM-CSF from BM precursors in the absence 
or presence of TvSP. (A-E) Immature DCs were stimulated with 100 ng/ml LPS for 6 h, and the mRNA levels of Il12a (A), Il12b (B), Il10
(C), Tnf (D), and Il6 (E) were measured by qRT-PCR. (F-I) Immature DCs were stimulated with 100 ng/ml LPS for 24 h, and the expre-
ssion of IL-12 (F), IL-10 (G), TNF-α (H), and IL-6 (I) was measured by Cytometric Bead Array. All data are expressed as mean ± SD, and 
statistical significance (*P ＜ 0.05, or **P ＜ 0.01) is shown for treatments compared with the controls.
increased by TvSP (Fig. 2G). The production of TNF-α and IL-6 
were independent of TvSP treatment during BMDC differ-
entiation (Fig. 2H and 2I).
The DC-modulatory activity of TvSP is abolished by treatment 
with Proteinase K
To understand the components of TvSP that are responsible for 
the regulation of surface molecule expression and cytokine 
production, we treated TvSP with Proteinase K and examined 
the effects on BMDCs. Compared to the mock-treated TvSP, 
which down-regulated expression of MHC-II, CD40, CD80, 
and CD86 especially when BMDCs were treated with LPS, 
treatment of TvSP with Proteinase K abrogated its inhibitory 
activity on the expression of these surface molecules (Fig. 
3A-3D). The down-regulation of IL-12 production and up-regu-
lation of IL-10 expression by TvSP also were abolished by 
Proteinase K treatment (Fig. 3E and 3F). These results show 
that a proteinaceous component of TvSP was responsible for 
the modulatory functions of BMDCs during differentiation with 
GM-CSF.
The effect of TvSP on the LPS-mediated signaling in BMDCs
We next investigated the effect of TvSP on the signaling path-
ways activated by LPS in BMDCs. Three main families of MAP 
kinases including ERK, p38 MAPK, and JNK are reported to be 
involved in signal transduction during LPS-induced DC activa-
tion (21, 22). Phosphorylation of these kinases induced by LPS 
treatment in BMDCs that were differentiated in the presence of 
Proteinase K-treated PBS, mock-treated TvSP, and Proteinase 
K-treated TvSP was comparable to that in control BMDCs 
(Supplementary Fig. 2A). We also examined the effect of TvSP 
on NF-kB activation, but no significant difference was ob-
served between BMDCs differentiated in the absence or pres-
ence of TvSP (Supplementary 2B). These data indicate that 
down-regulation of surface molecules and the altered cytokine 
production profile in BMDCs differentiated in the presence of 
TvSP may not be attributed to a defect in ERK, p38 MAPK, 
JNK, or NF-kB activation.
The effect of TvSP on the chromatin structure of cytokine 
genes in BMDCs
Regions of open chromatin are typically associated with tran-
scriptionally permissive histone modifications, which are par-
alleled by accessibility to transcription factors (23). We per-
formed chromatin immunoprecipitation (ChIP) assays to detect 
trimethyl-histone H3 Lys4 (H3K4me3), a histone modification 
specifically enriched at active or poised transcription start sites. 
Compared to the control BMDCs, enrichment of H3K4me3 
was clearly reduced at the promoter region of the Il12a gene 
in TvSP-treated BMDCs (Fig. 4A). In contrast, there were no 
significant differences in H3K4me3 levels at the promoter re-
gions of the Il12b, Il10, Tnf, Il6, and Gapdh genes regardless 
of TvSP treatment (Fig. 4B-4F). These data demonstrated that 
transcriptional repression of the Il12a gene encoding IL-12p35 
in TvSP-treated BMDCs takes place at the chromatin level and 
TvSP treatment during BMDCs differentiation altered the chro-
matin structure to be less accessible to the transcription factors 
required for gene expression.
DISCUSSION
In this study, we investigated the function of BMDCs that were 
exposed to soluble factors secreted from T. vaginalis during 
GM-CSF-mediated differentiation. Several lines of evidence 
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Fig. 3. The DC-modulatory activity of 
TvSP is abolished by treatment with 
Proteinase K. DCs were differentiated 
with GM-CSF from BM precursors in 
the presence of mock-treated or Pro-
teinase K-treated TvSP. (A-D) On day 
10, DCs were treated with 100 ng/ml 
LPS for 24 h to induce maturation, 
and expression of MHC-II (A), CD40 
(B), CD80 (C) and CD86 (D) was an-
alyzed by flow cytometry. Isotype con-
trols are shown as shaded histograms, 
control BMDCs are shown as red lines,
and TvSP-treated BMDCs are shown 
as blue lines. Mean fluorescent inten-
sity (MFI) values are indicated with 
corresponding colors. Results are rep-
resentative of more than three in-
dependent experiments. (E, F) Production
of cytokines IL-12 (E) and IL-10 (F) in-
duced by LPS (100 ng/ml) treatment 
of BMDCs for 24 h as measured by 
cytometric bead array. All data are ex-
pressed as the means ± SD (n = 3), 
and statistical significance (*P ＜ 0.05)
is shown for treatments compared with
the controls.
suggest that T. vaginalis can interfere with DC function without 
the need for direct cell-to-cell contact, by promoting immune 
tolerance and immune escape. First, TvSP can impair the ex-
pression of several surface molecules that play main roles in 
co-stimulation and antigen presentation to T cells. During dif-
ferentiation, DCs up-regulate the expression of MHC-II and 
co-stimulatory molecules such as CD40, CD80, and CD86 and 
thus increase their efficiency as antigen-presenting cells. 
BMDCs differentiated in the presence of TvSP exhibited a sig-
nificant defect in the expression of MHC-II and co-stimulatory 
molecules especially when the BMDCs were activated by LPS 
(Fig. 1). Second, BMDCs differentiated in the presence of TvSP 
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Fig. 4. TvSP exhibit epigenetic control 
via modulation of histone modifica-
tions at the promoter region of the 
Il12a gene. DCs were differentiated 
with GM-CSF from BM precursors in 
the absence or presence of TvSP. On 
day 10, LPS (100 ng/ml) was added 
to the culture for 1 h and H3K4me3 
levels at the promoter regions of Il12a
(A), Il12b (B), Il10 (C), Tnf (D), Il6 (E) 
and Gapdh (F) genes were analyzed 
by ChIP assay. *P ＜ 0.05 compared 
with untreated cells. Results are repre-
sentative of more than three indepen-
dent experiments.
showed an altered cytokine production profile in response to 
Toll-like receptor 4 (TLR4)-mediated LPS signaling, as a marked 
reduction in pro-inflammatory cytokine IL-12 secretion and en-
hanced production of anti-inflammatory cytokine IL-10 were ob-
served upon stimulation with LPS (Fig. 2). Interestingly, the ex-
pression of other pro-inflammatory cytokines such as TNF-α 
and IL-6 was comparable between BMDCs differentiated in the 
absence or presence of TvSP, demonstrating that there is a sep-
arate regulation mechanism involved in the expression of each 
pro-inflammatory cytokine. Although it was reported that in-
fection with T. vaginalis induced apoptosis of macrophages 
(18), the inhibition of DC maturation and altered cytokine pro-
duction profiles in TvSP- treated BMDCs was not due to cyto-
toxicity because TvSP did not trigger significant apoptosis in 
BMDCs (Supplementary Fig. 1). These data suggest that T. vagi-
nalis, via soluble products released during chronic infection, 
has the ability to shift an aggressive immune environment to-
ward a more permissive one to promote its survival.
Treatment of TvSP with Proteinase K abolished its effect on 
DC including down-regulation of surface molecules and IL-12 
production as well as up-regulation of IL-10 production (Fig. 3), 
suggesting that a proteinaceous TvSP component was nece-
ssary. However, we cannot entirely exclude contributions by 
any non-protein immunomodulatory components of TvSP, 
which might be thermally unstable. The identification of DC 
modulators secreted from T. vaginalis is an area for future 
investigation. The profiles of ERK, p38 MAPK, JNK, and NF-kB 
activation after LPS treatment is normal in BMDCs differ-
entiated in the presence of TvSP (Supplementary Fig. 2), imply-
ing that TvSP may modulate the activity of BMDCs via distinct 
kinase pathways that have yet to be determined. 
Epigenetic control and associated chromatin structure are 
particularly significant contributors to gene regulation and 
therefore play major roles in determining and maintaining cell 
differentiation (24). Various types of posttranslational histone 
modifications, including acetylation and methylation, dictate 
the dynamic transition between transcriptionally active or silent 
chromatin structures (25). To determine whether histone meth-
ylation plays a role in dysregulated cytokine gene expression in 
TvSP-treated BMDCs, we performed a ChIP assay using an anti-
body against H3K4me3, a stable ‘‘mark’’ associated with ac-
tively-transcribed chromatin. As shown in Fig. 4A, the level of 
H3K4me3 in the Il12a promoter was significantly reduced in 
TvSP-treated BMDCs, suggesting that the down-regulation of 
Il12a gene expression in these cells is associated with transcrip-
tionally less permissive histone modifications. In contrast, TvSP 
had no effect on enrichment of H3K4me3 in other promoters 
including Il12b and Il10 genes. How down-regulation of Il12b 
and up-regulation of Il10 are regulated by TvSP during BMDC 
differentiation remains to be investigated.
The data presented here demonstrate that soluble factors re-
leased by T. vaginalis, via a mostly proteinaceous component, 
control the LPS-induced maturation of BMDCs, resulting in a 
reduced production of IL-12 through an epigenetic mechanism. 
Considering the importance of IL-12 and IL-10 as well as the 
full activation of DC to efficiently prime T cells in the immune 
response against T. vaginalis, the ability of T. vaginalis to mod-
ulate these specific functions appears to be an effective im-
mune evasion strategy.
MATERIALS AND METHODS
Detailed experimental procedures are described in online 
Supplementary information.
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